Chong Li

4.1k total citations · 2 hit papers
92 papers, 3.1k citations indexed

About

Chong Li is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Chong Li has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 11 papers in Biomedical Engineering and 10 papers in Biomaterials. Recurrent topics in Chong Li's work include Advanced biosensing and bioanalysis techniques (17 papers), RNA Interference and Gene Delivery (12 papers) and Nanoparticle-Based Drug Delivery (8 papers). Chong Li is often cited by papers focused on Advanced biosensing and bioanalysis techniques (17 papers), RNA Interference and Gene Delivery (12 papers) and Nanoparticle-Based Drug Delivery (8 papers). Chong Li collaborates with scholars based in China, United States and Macao. Chong Li's co-authors include Xiaoyou Wang, Guojian Liao, Yixuan Tang, Huile Gao, Yong Gan, Zhangbao Chen, Yiguang Wang, Haijun Yu, Yongjun Wang and Jiancheng Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Neuron.

In The Last Decade

Chong Li

87 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent progress in drug delivery

2019 607 citations Chong Li et al. Acta Pharmaceutica Sinica B profile →
Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke

2021 185 citations Chong Li, Guangchi Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chong Li China	30	1.4k	822	712	336	290	92	3.1k
Siyuan Zhou China	35	1.4k 1.0×	651 0.8×	670 0.9×	236 0.7×	306 1.1×	177	3.8k
Subhra Mohapatra United States	31	1.2k 0.8×	666 0.8×	478 0.7×	257 0.8×	274 0.9×	112	3.3k
Hiroyuki Koide Japan	25	1.3k 0.9×	609 0.7×	644 0.9×	118 0.4×	230 0.8×	64	2.8k
Wei Ren China	33	1.4k 1.0×	658 0.8×	668 0.9×	548 1.6×	245 0.8×	164	3.5k
Xiaoyu Xu China	32	1.6k 1.1×	530 0.6×	239 0.3×	178 0.5×	167 0.6×	224	4.1k
Jianbo Ji China	37	989 0.7×	1.1k 1.3×	877 1.2×	341 1.0×	407 1.4×	130	3.3k
Tomohiro Asai Japan	38	2.5k 1.7×	807 1.0×	1.3k 1.8×	461 1.4×	218 0.8×	161	4.6k
Yao Fu China	36	1.9k 1.3×	866 1.1×	1.1k 1.6×	391 1.2×	237 0.8×	161	4.2k
Wenfeng Zeng China	29	1.9k 1.3×	1.2k 1.4×	606 0.9×	230 0.7×	481 1.7×	63	4.0k
Yue Gao China	34	1.9k 1.3×	831 1.0×	576 0.8×	221 0.7×	430 1.5×	184	3.8k

Countries citing papers authored by Chong Li

Since Specialization

Citations

This map shows the geographic impact of Chong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Li more than expected).

Fields of papers citing papers by Chong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Li. The network helps show where Chong Li may publish in the future.

Co-authorship network of co-authors of Chong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Li. A scholar is included among the top collaborators of Chong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Li. Chong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Zhongjie, Miaomiao Niu, Weiwei Xue, et al.. (2025). Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nature Communications. 16(1). 3410–3410. 6 indexed citations

Zha, Menglei, Jen‐Shyang Ni, Yaxi Li, et al.. (2025). Repurposing clinical iron oxide agents for mild hyperthermia-assisted cancer therapy. Cell Reports Physical Science. 6(12). 102977–102977.

Li, Chong, et al.. (2025). Measurement of differential activation by heart-rate-variability for youth MDD discrimination. Journal of Affective Disorders. 376. 169–176. 1 indexed citations

Guo, Qian, Lee‐Fong Yau, Ling Yang, et al.. (2025). Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nature Communications. 16(1). 2368–2368. 8 indexed citations

Li, Chong, Yihan Wang, Jingjing Wang, et al.. (2025). The relationship between benevolent childhood experiences and depression among Chinese university students: the serial mediating role of family relationships and sleep quality. Frontiers in Public Health. 13. 1450932–1450932. 3 indexed citations

Li, Chong, et al.. (2025). What makes a specialised emergency plan effective?—A case study of railway operation in 33 prefectural cities in China. PLoS ONE. 20(7). e0327007–e0327007.

Yang, Ling, Adam Grippin, Yifan Ma, et al.. (2024). Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles. Nature Communications. 15(1). 3987–3987. 18 indexed citations

Li, Qiyu, et al.. (2024). Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer. Journal of Nanobiotechnology. 22(1). 674–674. 11 indexed citations

Li, Chong, Yu Tian Wang, Wenjing Zhang, et al.. (2024). The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability. Frontiers in Oncology. 14. 1506588–1506588. 2 indexed citations

10.

Liu, Tong‐Bao, et al.. (2023). Antifungal therapy: Novel drug delivery strategies driven by new targets. Advanced Drug Delivery Reviews. 199. 114967–114967. 24 indexed citations

11.

Bao, Zhongyuan, Yinlong Liu, Binglin Chen, et al.. (2021). Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury. Nature Communications. 12(1). 4220–4220. 96 indexed citations

12.

Bao, Zhongyuan, Kai-Heng Fang, Zong Miao, et al.. (2021). Human Cerebral Organoid Implantation Alleviated the Neurological Deficits of Traumatic Brain Injury in Mice. Oxidative Medicine and Cellular Longevity. 2021(1). 6338722–6338722. 33 indexed citations

13.

Tu, Yiming, Zhenyao Chen, Pengzhan Zhao, et al.. (2020). Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination. Clinical Cancer Research. 26(7). 1749–1762. 40 indexed citations

14.

Kang, Xing, et al.. (2019). A Novel Monoclonal Antibody PC322 Inhibit Prostate Cancer Cell Autophagy. 1(1).

15.

Jiang, Hong, et al.. (2016). Self-enhanced targeted delivery of a cell wall– and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia. Acta Pharmaceutica Sinica B. 6(4). 319–328. 25 indexed citations

16.

Zhan, Changyou, et al.. (2015). Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy. Advanced Drug Delivery Reviews. 90. 101–118. 40 indexed citations

17.

Zhang, Yan, Sha Liu, Jin Wu, et al.. (2015). Active Targeting of Tumors through Conformational Epitope Imprinting. Angewandte Chemie International Edition. 54(17). 5157–5160. 127 indexed citations

18.

Li, Chong, Zhao Yang, Ying Du, et al.. (2014). BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer In Vivo. Clinical Cancer Research. 20(15). 4001–4013. 36 indexed citations

19.

Wu, Bo, Guangyan Zhong, Yue Jian-qiang, et al.. (2014). Identification of Pummelo Cultivars by Using a Panel of 25 Selected SNPs and 12 DNA Segments. PLoS ONE. 9(4). e94506–e94506. 20 indexed citations

20.

Li, Chong, et al.. (2012). Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. International Journal of Nanomedicine. 7. 5995–5995. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact